Biosativa Labs hereby informs that there has been a modification in the secondary packaging of the product Biosativa 1500 mg (CBD, THC, CBG, CBC – 30 mL – 0.2% THC), exclusively for marketing purposes and to better adapt to the Brazilian market. It is important to note that the product’s formula and composition remain unchanged.
Read PT-BR version click here.
Change: Only in the secondary packaging (outer box, labeling, and graphic design).
Purpose: Adjustment to the preferences and communication needs of patients in Brazil.
Impact: There is no impact on the product’s composition, safety, or efficacy.
The active ingredient is a 100% organic extract, naturally obtained and subjected to rigorous quality control processes.
These processes include:
The maintenance of the formula is ensured through the Certificate of Analysis (COA), available here.
As a product of natural origin, minor physicochemical variations may occur without affecting the efficacy or quality of the medication, such as:
These variations are due to the seasonality of plant harvests and are inherent to natural and organic herbal products.
Patients can be assured that:
The change made refers exclusively to the secondary packaging.
The product’s formula, active ingredient, and concentrations remain unchanged, guaranteed by laboratory analyses and the COA available online.
Any physical variations are natural and expected in plant-based products and do not compromise quality or efficacy.